We serve Chemical Name:1-(2-Methylphenyl)piperidin-4-one CAS:218610-72-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(2-Methylphenyl)piperidin-4-one
CAS.NO:218610-72-1
Synonyms:1-(2-Methylphenyl)piperidin-4-one
Molecular Formula:C12H15NO
Molecular Weight:189.25400
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:325.9ºC at 760 mmHg
Density:1.084g/cm3
Index of Refraction:1.555
PSA:20.31000
Exact Mass:189.11500
LogP:2.22930
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like 1-(2-Methylphenyl)piperidin-4-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(2-Methylphenyl)piperidin-4-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(2-Methylphenyl)piperidin-4-one Use and application,1-(2-Methylphenyl)piperidin-4-one technical grade,usp/ep/jp grade.
Related News: API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine. 1-(2-Methylphenyl)piperidin-4-one manufacturer The FDA also said that the labeling of the diagnostic, which comes in different versions, included performance claims that did not match up with results seen in clinical studies—and that the data Innova submitted for review “was identical to data previously provided by other manufacturers” in separate requests for emergency COVID authorizations, raising additional questions. 1-(2-Methylphenyl)piperidin-4-one supplier But Vietnam then partly eased its ban, allowing flights from Hong Kong and Macau to continue, aviation authorities said. 1-(2-Methylphenyl)piperidin-4-one vendor API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine. 1-(2-Methylphenyl)piperidin-4-one factory Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.